In a population of asbestos-exposed subjects who eventually developed malignant mesothelioma, ENOX2 transcript variants characteristic of malignant mesothelioma were present in serum 4–10 years in advance of clinical symptoms. This evidence concerns the gene ENOX2 and malignant mesothelioma.